Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

MS relapses are more common in spring and summer, coinciding with warmer, drier weather and atmospheric changes, a study ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

For more than two decades, audiences have known actress Selma Blair for her unforgettable performances in films such as Cruel Intentions and Legally Blonde. Away from the spotlight, though, she was ...

JACKSONVILLE, Fla. — For many, the holiday season brings celebration, travel and time with loved ones. But for people in recovery from substance use, it can also bring disrupted routines, heightened ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, December 17, 2025. Let’s ...

Tolebrutinib, which Sanofi acquired in a $3.7 billion buyout, failed a Phase 3 study in “primary progressive” multiple sclerosis and is facing a delayed U.S. approval decision in another form of the ...

Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.